Skip to main content
Top

Journal of Endocrinological Investigation

Issue 11/2014

Content (14 Articles)

Short Review

An update on the medical treatment of Graves’ hyperthyroidism

Michele Marinò, Francesco Latrofa, Francesca Menconi, Luca Chiovato, Paolo Vitti

Open Access Short Review

Functional hypothalamic amenorrhea and its influence on women’s health

B. Meczekalski, K. Katulski, A. Czyzyk, A. Podfigurna-Stopa, M. Maciejewska-Jeske

Original Article

Evaluation of long-term pituitary functions in patients with severe ventricular arrhythmia: a pilot study

Y. Simsek, M. G. Kaya, F. Tanriverdi, B. Çalapkorur, H. Diri, Z. Karaca, K. Unluhizarci, F. Kelestimur

Original Article

The environmental pollutant cadmium induces homeostasis alteration in muscle cells in vitro

V. Papa, F. Wannenes, C. Crescioli, D. Caporossi, A. Lenzi, S. Migliaccio, L. Di Luigi

Original Article

Quantifying subtle changes in cardiovascular mechanics in acromegaly: a Doppler myocardial imaging study

R. Jurcut, S. Găloiu, A. Florian, A. Vlădaia, O. R. Ioniţă, M. S. Amzulescu, I. Baciu, B. A. Popescu, M. Coculescu, C. Ginghina

Original Article

Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis

L. Mortara, G. Pera, E. Monti, S. Morbelli, F. Minuto, G. Sambuceti, M. Giusti

Opinion

Alpha Klotho and phosphate homeostasis

A. Bian, C. Xing, M. C. Hu

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine